NASDAQ:NUVA
Delisted
NuVasive Stock News
$39.75
+0 (+0%)
At Close: Nov 30, 2023
NuVasive (NUVA) to Expand in APAC With New Experience Center
02:34pm, Monday, 04'th Jul 2022 Zacks Investment Research
NuVasive's (NUVA) Singapore Experience Center will complement the flagship Experience Centers in San Diego and the New York metropolitan area.
Why Is Perrigo (PRGO) Up 13.4% Since Last Earnings Report?
03:30pm, Friday, 10'th Jun 2022 Zacks Investment Research
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
National Vision (EYE) Up 21.6% Since Last Earnings Report: Can It Continue?
03:30pm, Thursday, 09'th Jun 2022 Zacks Investment Research
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold on to NuVasive (NUVA) Stock for Now
02:08pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Investors are optimistic about NuVasive (NUVA) on strong sales performance across the U.S. spinal hardware and the U.S. surgical support product lines.
Why Is NuVasive (NUVA) Up 6.3% Since Last Earnings Report?
03:31pm, Friday, 03'rd Jun 2022 Zacks Investment Research
NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NuVasive (NUVA) is a Top-Ranked Value Stock: Should You Buy?
01:40pm, Thursday, 26'th May 2022 Zacks Investment Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
NuVasive (NUVA) is a Top-Ranked Value Stock: Should You Buy?
11:18am, Thursday, 26'th May 2022
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
4 Analysts Have This to Say About NuVasive
04:11pm, Friday, 06'th May 2022 Benzinga
Analysts have provided the following ratings for NuVasive (NASDAQ:NUVA) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
1
0
0
Last 3
NuVasive (NUVA) Q1 Earnings Beat Estimates, 2022 View Up
01:41pm, Thursday, 05'th May 2022 Zacks Investment Research
Robust sales performance across all U.S. product lines drove NuVasive's (NUVA) Q1 top line.
NuVasive (NUVA) Q1 Earnings Beat Estimates, 2022 View Up
11:23am, Thursday, 05'th May 2022
Robust sales performance across all U.S. product lines drove NuVasive's (NUVA) Q1 top line.
NuVasive (NUVA) Tops Q1 Earnings and Revenue Estimates
10:35pm, Wednesday, 04'th May 2022 Zacks Investment Research
NuVasive (NUVA) delivered earnings and revenue surprises of 42.11% and 4.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
NuVasive, Inc. (NUVA) CEO Chris Barry on Q1 2022 Earnings Call Transcript
10:01pm, Wednesday, 04'th May 2022
NuVasive, Inc. (NASDAQ:NUVA ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Juliet Cunningham - VP, IR Chris Barry - CEO Matt Harbaugh - CFO Conference Call Participants
NuVasive (NUVA) Tops Q1 Earnings and Revenue Estimates
08:18pm, Wednesday, 04'th May 2022
NuVasive (NUVA) delivered earnings and revenue surprises of 42.11% and 4.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MedTech Stocks' Q1 Earnings Due on May 4: CRL, IDXX & NUVA
02:34pm, Tuesday, 03'rd May 2022 Zacks Investment Research
MedTech companies' results are likely to reflect a rebound in the base business. Let's see how CRL, IDXX and NUVA fare this time.
MedTech Stocks' Q1 Earnings Due on May 4: CRL, IDXX & NUVA
12:02pm, Tuesday, 03'rd May 2022
MedTech companies' results are likely to reflect a rebound in the base business. Let's see how CRL, IDXX and NUVA fare this time.
